Additional information
| Strength | 0.25MG, 0.5MG, 1 MG, 1.7MG, 2.4MG, 7.2MG |
|---|---|
| Quantity | 1 MONTH SUPPLY, 2 MONTH SUPPLY, 3 MONTH SUPPLY |
Wegovy is a prescription weight management treatment containing semaglutide, a GLP-1 receptor agonist. It is administered as a once-weekly injection and may help eligible patients with obesity manage their weight when used alongside lifestyle changes and under appropriate medical supervision.
£99.99 – £749.99Price range: £99.99 through £749.99

Safe & compliant prescribing

UK-Registered Pharmacy

Quick, hassle-free online consultation

Your data is 100% protected

Next-day UK delivery available

NHS Providing Service since 2020
| Strength | 0.25MG, 0.5MG, 1 MG, 1.7MG, 2.4MG, 7.2MG |
|---|---|
| Quantity | 1 MONTH SUPPLY, 2 MONTH SUPPLY, 3 MONTH SUPPLY |
What is Wegovy and what is it used for?
Wegovy is a prescription-only weight management medicine containing semaglutide. It belongs to a class of medicines known as GLP-1 receptor agonists and is administered as an injection once a week.
Wegovy is used to support long-term weight management alongside a reduced-calorie diet, regular physical activity and sustainable lifestyle changes. It may be suitable for people who meet the relevant clinical criteria and have found it difficult to manage their weight through diet and exercise alone.
Rather than providing a short-term approach to weight loss, Wegovy works by helping to regulate appetite. This can help some people feel satisfied with smaller portions, experience less hunger between meals and find it easier to manage food cravings.
When combined with appropriate lifestyle changes, clinical studies have shown that semaglutide can support significant weight reduction. However, individual results vary and no specific amount of weight loss can be guaranteed.
What is GLP-1 and how does Wegovy support weight loss?
GLP-1, or glucagon-like peptide-1, is a hormone naturally produced by the body. One of its roles is to help regulate appetite and feelings of fullness after eating.
Semaglutide, the active ingredient in Wegovy, acts in a similar way to naturally occurring GLP-1. It works on areas involved in appetite regulation, helping to reduce hunger and increase feelings of fullness.
For suitable patients, this may make it easier to:
Wegovy is most effective when it forms part of a wider weight-management programme that includes healthy eating, physical activity and long-term lifestyle changes.
Treatment should not be viewed as a replacement for diet and exercise. Instead, it can provide additional medical support to help eligible patients manage their appetite and calorie intake.
Who may be eligible for Wegovy?
For adult weight management, Wegovy may be considered for people with:
Examples of weight-related health conditions can include:
Eligibility for Wegovy is not determined by BMI alone.
Before prescribing treatment, a healthcare professional will assess factors including your medical history, current medicines, existing health conditions and overall suitability for treatment.
At Chesterfield Delivery Pharmacy, an appropriate clinical consultation must be completed before Wegovy can be considered. Providing complete and accurate health information is essential so that the prescriber can make an informed decision about whether the treatment is suitable for you.
Completing a consultation does not guarantee that Wegovy will be prescribed.
Who may not be suitable for Wegovy?
Wegovy is not appropriate for everyone. Your individual circumstances must be reviewed by a qualified healthcare professional before treatment begins.
Wegovy should not be used during pregnancy and is not normally recommended while breastfeeding.
You should make your prescriber aware if you:
Providing accurate medical information during your consultation helps the clinical team determine whether Wegovy is safe and appropriate for you.
Wegovy also has a licensed weight-management indication for certain adolescents aged 12 years and over who meet specific clinical criteria. Availability through Chesterfield Delivery Pharmacy will depend on the scope of the pharmacy’s prescribing service and an appropriate clinical assessment.
What is the Wegovy dosing schedule?
Wegovy is normally taken once a week using a pre-filled injection pen.
Treatment begins with a low dose and gradually increases. This step-by-step approach gives the body time to adjust to semaglutide and can help reduce gastrointestinal side effects.
The standard adult Wegovy dose escalation schedule is:
For certain adults with obesity, a higher 7.2 mg maintenance dose may be considered if clinically appropriate after at least four weeks at the 2.4 mg dose.
Your prescriber will determine the most appropriate dose for you based on your response to treatment, side effects and individual medical circumstances.
Never increase or change your Wegovy dose without advice from the healthcare professional responsible for your treatment.
Alongside Wegovy treatment, patients should aim to maintain healthy lifestyle habits including:
Wegovy 7.2 mg
Wegovy is also licensed in the UK at a higher 7.2 mg once-weekly maintenance dose for certain adults with obesity.
The 7.2 mg strength is not intended as a starting dose.
Patients normally begin Wegovy treatment at 0.25 mg and gradually work through the recommended dose escalation schedule. For adults with obesity who require additional treatment benefit, a prescriber may consider increasing the dose from 2.4 mg to 7.2 mg after the patient has remained on 2.4 mg for at least four weeks.
Suitability for the higher dose must always be assessed individually.
A single-dose Wegovy 7.2 mg pre-filled pen is now licensed in the UK, allowing the 7.2 mg weekly dose to be administered in one injection.
Depending on the specific product supplied and the instructions provided by your prescriber, the 7.2 mg weekly dose may also be administered using three 2.4 mg injections.
Do not use the 7.2 mg dose unless it has specifically been prescribed for you.
How effective is Wegovy 7.2 mg?
The STEP UP clinical study assessed the higher 7.2 mg dose of semaglutide in adults with obesity over a period of 72 weeks.
When analysing participants who remained on their assigned treatment without using another weight-management medicine or undergoing bariatric surgery, estimated average body-weight reduction was approximately:
Using an analysis that included participants regardless of treatment discontinuation or additional weight-management interventions, average weight reduction was approximately:
These figures are averages from clinical trials and should not be taken as a prediction of how much weight an individual patient will lose.
Your results can be influenced by a number of factors, including your starting weight, diet, physical activity, treatment adherence, dose and individual response to semaglutide.
Wegovy 7.2 mg vs Mounjaro 15 mg
Wegovy and Mounjaro are both prescription weight-management treatments, but they contain different active ingredients and act on the body in different ways.
| Feature | Wegovy 7.2 mg | Mounjaro 15 mg |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| How it works | GLP-1 receptor agonist | Dual GIP and GLP-1 receptor agonist |
| Highest weekly dose | 7.2 mg | 15 mg |
| How often is it taken? | Once weekly | Once weekly |
| Weight reduction reported in relevant trials | Approximately 20.7% at 72 weeks in an on-treatment analysis | Approximately 22.5% at 72 weeks in SURMOUNT-1 |
| UK prescription required? | Yes | Yes |
These results come from separate clinical studies involving different groups of participants and should not be interpreted as a direct comparison between the two medicines.
Average trial results also do not guarantee that an individual patient will achieve the same level of weight reduction.
The most appropriate treatment will depend on factors including your BMI, health conditions, current medication, previous treatments, potential side effects and clinical history.
A healthcare professional can assess your circumstances and determine which treatment, if either, may be appropriate.
Considering Wegovy or Mounjaro?
If you are unsure which weight-management treatment may be appropriate for you, complete a consultation with Chesterfield Delivery Pharmacy.
A healthcare professional can review your medical information and determine whether prescription weight-management treatment is suitable.
Start Your Consultation
Complete the Chesterfield Delivery Pharmacy weight-management consultation to begin your clinical assessment.
How does the cost of Wegovy vary by dose?
The price of Wegovy can vary depending on the strength prescribed.
Patients normally begin treatment at the lowest 0.25 mg dose before gradually progressing through the Wegovy dosing schedule. Lower strengths are therefore generally used during the initial dose escalation period rather than as the long-term maintenance dose.
For many patients, 2.4 mg is the standard maintenance dose, although some adults with obesity may be considered for 7.2 mg where clinically appropriate.
When considering the cost of Wegovy treatment, it is useful to consider the potential ongoing monthly cost rather than focusing only on the price of the starter dose.
Chesterfield Delivery Pharmacy provides clear pricing across the available Wegovy strengths, with treatment subject to an appropriate clinical assessment and prescription.
How much does Wegovy cost?
| Wegovy Dose | 1 Pen (4 Doses) | 2 Pens (8 Doses) | 3 Pens (12 Doses) |
|---|---|---|---|
| 0.25 mg | £99.99 | £199.98 | £279.99 |
| 0.5 mg | £129.99 | £259.98 | £389.97 |
| 1 mg | £129.99 | £259.98 | £389.97 |
| 1.7 mg | £179.99 | £359.98 | £539.97 |
| 2.4 mg | £229.99 | £459.98 | £689.97 |
| 7.2 mg | £249.99 | £499.99 | £749.99 |
Prices should be confirmed against the current Chesterfield Delivery Pharmacy price list before ordering. The strength supplied will depend on your treatment stage and the dose considered clinically appropriate by your prescriber.
How much weight could I lose with Wegovy?
The amount of weight people lose while using Wegovy varies considerably.
Clinical studies of semaglutide have demonstrated meaningful average reductions in body weight when treatment is combined with a reduced-calorie diet and increased physical activity.
Results depend on a range of factors, including:
Some patients may lose considerably more or less weight than the averages reported in clinical trials.
A weight-loss calculator can provide an illustration based on percentage weight reduction, but it cannot predict your individual treatment outcome.
Use the calculator below to explore different potential weight-loss scenarios and help set realistic goals before beginning treatment with Chesterfield Delivery Pharmacy.
Important Information
Wegovy is a prescription-only medicine.
Treatment is subject to a clinical assessment and must only be used exactly as directed by your prescriber.
The information provided on this page is for general educational purposes and does not replace advice from your doctor, pharmacist or prescribing healthcare professional.
How is Wegovy injected?
Wegovy is supplied as a pre-filled injection pen containing semaglutide. It is normally administered once a week as an injection under the skin, known as a subcutaneous injection.
Your Wegovy pen is prescribed specifically for you and should never be shared with another person.
Always follow the instructions provided by your prescriber and carefully read the Patient Information Leaflet supplied with your medicine before using Wegovy for the first time.
Choosing your weekly Wegovy injection day
Choose a day of the week that is easy for you to remember.
Keeping a regular weekly routine can make it easier to remember when your next injection is due.
If you need to change your regular injection day, speak to your pharmacist or prescriber or follow the instructions provided with your medicine.
How to use a Wegovy injection pen
Before injecting Wegovy, make sure you understand how to use the specific pen you have been supplied with.
For the standard Wegovy FlexTouch pen:
Different Wegovy pen presentations may have different operating instructions. Always follow the instructions supplied with your particular pen rather than relying solely on general injection guidance.
Where should Wegovy be injected?
Wegovy is injected into the fatty tissue directly beneath the skin.
Recommended injection areas include:
Try to vary the exact injection site each week rather than repeatedly injecting into the same area.
Avoid injecting Wegovy into skin that is:
Wegovy should not be injected directly into a vein or muscle.
If you are unsure how or where to administer your injection, speak to your doctor, pharmacist or nurse before using the medicine.
What should I do if I miss a Wegovy dose?
If you forget to take your scheduled weekly Wegovy injection:
Do not take a double dose to make up for a forgotten injection.
If you have missed several doses or are unsure when to restart treatment, contact your prescriber or pharmacist for advice before taking another injection.
How should Wegovy be stored?
Correct storage helps ensure that Wegovy remains suitable for use.
For standard Wegovy FlexTouch pens:
Storage instructions can vary between different Wegovy pen presentations, including the newer 7.2 mg pen. Always check the Patient Information Leaflet supplied with your particular medicine and follow the storage instructions shown on the packaging.
Do not use Wegovy after the expiry date shown on the pen or carton.
Safe disposal of Wegovy pens and needles
Used needles should be placed immediately into an approved sharps container and should never be reused or shared.
Do not dispose of unused medicine through household wastewater. Ask Chesterfield Delivery Pharmacy, your pharmacist or another healthcare professional for advice on safely disposing of medicines and injection equipment that you no longer need.
Important Information
Wegovy is a prescription-only medicine containing semaglutide.
Always use Wegovy exactly as prescribed and follow the Patient Information Leaflet supplied with your medicine. If you are unsure how to administer your injection, contact your doctor, pharmacist, nurse or prescribing healthcare professional before using it.
Wegovy Side Effects
What are the possible side effects of Wegovy?
Like all medicines, Wegovy can cause side effects, although not everyone who uses it will experience them.
The most commonly reported Wegovy side effects affect the digestive system. These can be more noticeable when treatment is first started or when your dose is increased. For many people, these symptoms become easier to manage as the body adjusts to semaglutide.
Always speak to your doctor, pharmacist or prescriber if you are concerned about a side effect or if symptoms become persistent or difficult to manage.
Common side effects of Wegovy
Commonly reported side effects can include:
Some people may also experience other effects such as changes in taste or hair loss.
Not everybody will experience the same symptoms, and the severity of side effects can vary from person to person.
More serious Wegovy side effects
Although less common, Wegovy can occasionally cause side effects that require prompt medical attention.
These can include:
If you experience severe or unusual symptoms while taking Wegovy, seek appropriate medical advice promptly.
Can Wegovy affect blood sugar levels?
Semaglutide can lower blood glucose levels.
The risk of hypoglycaemia (low blood sugar) may be greater if you have diabetes and use Wegovy alongside certain diabetes treatments, particularly insulin or sulfonylurea medicines.
Symptoms of low blood sugar can include:
If you have diabetes, tell your prescriber about all medicines you are currently using before starting Wegovy. Your existing diabetes treatment may need to be reviewed.
If you develop symptoms of severe hypoglycaemia, or symptoms do not improve after following your usual treatment for low blood sugar, seek urgent medical assistance.
How can I manage common Wegovy side effects?
Simple adjustments may help make some digestive side effects easier to manage.
You may find it helpful to:
Many gastrointestinal side effects are most noticeable during the early stages of treatment or following a dose increase.
If your symptoms are severe, persistent or affecting your ability to eat and drink normally, contact your prescriber.
When should I seek urgent medical advice while using Wegovy?
Seek urgent medical attention if you experience symptoms such as:
Do not ignore severe symptoms simply because they are listed as a possible side effect.
Wegovy and changes to eyesight
People with type 2 diabetes may experience complications relating to diabetic retinopathy, particularly if blood glucose levels improve rapidly.
If you have diabetic retinopathy or another existing eye condition, make sure your prescriber is aware before beginning treatment.
Seek medical attention if you notice a sudden deterioration or significant change in your vision while using semaglutide.
Before taking Wegovy
Before starting Wegovy, tell your prescriber about your medical history and all prescription, over-the-counter and complementary medicines you currently use.
This helps the clinical team at Chesterfield Delivery Pharmacy assess whether Wegovy is an appropriate treatment for you and identify any circumstances that may require additional monitoring.
Important information about Wegovy side effects
The information above does not include every possible side effect associated with semaglutide.
Always read the Patient Information Leaflet supplied with your Wegovy medicine before starting treatment and keep it available for future reference.
If you experience any side effects while using Wegovy, speak to your doctor, pharmacist, nurse or prescriber. Serious or unexpected side effects should receive appropriate medical attention.
Wegovy is a prescription-only medicine and should only be used exactly as prescribed.
Wegovy Warnings and Precautions
What should I know before using Wegovy?
Wegovy is a prescription-only medicine containing semaglutide and is not suitable for everyone. Before starting treatment, you will need to complete an appropriate clinical consultation so that a healthcare professional can review your medical history, current medicines and overall suitability.
Always use Wegovy exactly as prescribed. Treatment normally starts at a low dose which is gradually increased over several weeks. Increasing the dose faster than recommended may increase the likelihood of side effects, particularly nausea, vomiting, diarrhoea and other digestive symptoms.
Wegovy is intended to support long-term weight management and should be used alongside appropriate dietary changes, regular physical activity and sustainable lifestyle habits.
When should Wegovy not be used?
Do not use Wegovy if you are allergic to semaglutide or any of the other ingredients contained in the medicine.
Wegovy should not be used during pregnancy. If you are planning to become pregnant, semaglutide should normally be stopped at least two months before a planned pregnancy.
Wegovy should also not be used while breastfeeding.
If you become pregnant while taking Wegovy, contact your doctor or prescribing healthcare professional promptly.
Who should take extra care when using Wegovy?
Tell your prescriber before starting Wegovy if you:
Your prescriber may need to consider additional monitoring or decide whether another treatment would be more appropriate.
Wegovy and pancreatitis
Acute pancreatitis has been reported in people using GLP-1 medicines such as semaglutide.
Seek immediate medical attention if you develop severe and persistent abdominal pain, particularly if the pain spreads towards your back. The pain may occur with or without nausea or vomiting.
If pancreatitis is suspected, Wegovy should be stopped while you are medically assessed. If pancreatitis is confirmed, treatment should not normally be restarted.
Patients with a previous history of pancreatitis should make sure their prescriber is aware before beginning treatment.
Wegovy, nausea, vomiting and dehydration
Digestive side effects are relatively common with Wegovy, particularly when treatment begins or when the dose is increased.
These can include:
Vomiting and diarrhoea can cause dehydration. In rare circumstances, significant fluid loss may contribute to worsening kidney function, particularly in people who already have kidney problems.
Drink enough fluids during treatment and seek medical advice if vomiting or diarrhoea is persistent, severe or prevents you from keeping fluids down.
Wegovy and delayed digestion
Semaglutide can slow the rate at which food leaves the stomach.
This can contribute to symptoms such as:
Eating smaller meals, avoiding foods that make your symptoms worse and maintaining adequate fluid intake may help.
Contact your healthcare professional if digestive symptoms become severe or persistent.
Wegovy before surgery or sedation
Because Wegovy can delay stomach emptying, it is important to tell your doctor, surgeon or anaesthetist that you are taking semaglutide if you are due to have a medical procedure involving general anaesthesia or deep sedation.
Delayed stomach emptying may increase the amount of food or fluid remaining in the stomach during a procedure, which can increase the risk of aspiration.
Always follow the instructions given by your medical team before surgery or a procedure.
Wegovy and diabetes medicines
If you have diabetes, tell your prescriber before using Wegovy.
Wegovy must not be used as a replacement for insulin.
Taking semaglutide alongside insulin or certain diabetes medicines known as sulfonylureas may increase the risk of hypoglycaemia, or low blood sugar.
Possible symptoms include:
Your diabetes medication may need to be reviewed when Wegovy treatment begins.
Wegovy and diabetic eye disease
People with diabetes, particularly those with diabetic retinopathy, should inform their healthcare professional before starting treatment.
Changes in blood glucose levels may sometimes affect existing diabetic eye disease.
Contact your doctor promptly if you experience changes to your vision while using Wegovy.
Very rarely, semaglutide has also been associated with an eye condition known as non-arteritic anterior ischaemic optic neuropathy (NAION). Seek urgent medical advice if you notice sudden or progressively worsening loss of vision.
Wegovy and allergic reactions
Although uncommon, serious allergic reactions can occur.
Stop using Wegovy and seek urgent medical assistance if you experience symptoms such as:
These symptoms may indicate a serious allergic reaction requiring immediate treatment.
Using Wegovy safely
To help use Wegovy safely:
When should I seek urgent medical advice?
Get urgent medical help if you experience:
Important information before starting Wegovy
Always read the Patient Information Leaflet supplied with your Wegovy medicine before using it for the first time.
The leaflet contains the full list of warnings, precautions, interactions and possible side effects relevant to the particular Wegovy product you have been supplied.
At Chesterfield Delivery Pharmacy, prescription weight-management treatment is subject to an appropriate clinical assessment. The information on this page is intended as general guidance and should not replace personalised advice from your doctor, pharmacist or prescribing healthcare professional.
Wegovy Ingredients
What ingredients does Wegovy contain?
The active ingredient in Wegovy is semaglutide, a medicine belonging to a group known as GLP-1 receptor agonists.
Semaglutide helps regulate appetite and feelings of fullness, which can support weight management when Wegovy is used alongside a reduced-calorie diet and increased physical activity.
The other ingredients in Wegovy help maintain the stability, pH and consistency of the injectable solution. The exact ingredients can vary depending on the Wegovy strength and pen presentation supplied.
Ingredients in standard Wegovy FlexTouch pens
For Wegovy FlexTouch strengths including 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg, the other ingredients include:
Ingredients in Wegovy 7.2 mg
The newer Wegovy 7.2 mg single-dose pre-filled pen has a slightly different formulation.
In addition to semaglutide, it contains:
The 7.2 mg single-dose formulation does not contain the same combination of excipients as the standard multi-dose FlexTouch pens.
What is the active ingredient in Wegovy?
The active ingredient is semaglutide.
Semaglutide works by mimicking the activity of the naturally occurring GLP-1 hormone, which is involved in appetite regulation. This can help reduce hunger, increase feelings of fullness and support lower calorie intake.
Wegovy should always be used as part of a clinically appropriate weight-management programme and exactly as prescribed.
Does Wegovy contain lactose or gluten?
Lactose and gluten are not listed among the ingredients in the current UK Patient Information Leaflets for Wegovy.
If you have a known allergy, intolerance or sensitivity, you should still check the Patient Information Leaflet supplied with your particular Wegovy pen and discuss any concerns with your prescriber or pharmacist before starting treatment.
What if I am allergic to an ingredient in Wegovy?
Do not use Wegovy if you are allergic to semaglutide or any of the other ingredients contained in the specific product you have been prescribed.
Signs of a serious allergic reaction may include:
Seek urgent medical attention if you develop symptoms of a serious allergic reaction after using Wegovy.
Before treatment is prescribed through Chesterfield Delivery Pharmacy, make sure you provide accurate information about any known allergies or previous reactions to medicines.
Important information about Wegovy ingredients
The precise formulation may differ depending on the Wegovy strength or pen type supplied.
Always check the Patient Information Leaflet included with your medicine for the complete and most relevant ingredient list.
If you have concerns about any Wegovy ingredient, speak to your doctor, pharmacist or prescribing healthcare professional before administering your injection.







This website sells age-restricted products. Please confirm you are 18 years of age or older to continue.
Sorry, you must be 18 years or older to access this website.
Leave Site
Reviews
There are no reviews yet.